| Literature DB >> 24398050 |
Lawrence M Schell1, Mia V Gallo, Glenn D Deane, Kyrie R Nelder, Anthony P DeCaprio, Agnes Jacobs.
Abstract
BACKGROUND: Concern persists over endocrine-disrupting effects of persistent organic pollutants (POPs) on human growth and sexual maturation. Potential effects of toxicant exposures on testosterone levels during puberty are not well characterized.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24398050 PMCID: PMC3948020 DOI: 10.1289/ehp.1205984
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Characteristics of adolescent Akwesasne males: mean ± SD for all observations combined (n = 120) and by Tanner stage.
| Covariates and toxicants | All | TS I ( | TS II ( | TS III ( | TS IV ( | TS V ( |
|---|---|---|---|---|---|---|
| Age (years) | 13.17 ± 1.95 | 11.32 ± 1.09 | 11.93 ± 1.43 | 13.31 ± 1.51 | 14.62 ± 1.09 | 16.04 ± 0.81 |
| Testosterone (ng/dL) | 252.18 ± 279.60 | 26.41 ± 35.31 | 48.71 ± 90.71 | 264.70 ± 252.28 | 509.88 ± 203.42 | 555.70 ± 299.24 |
| Height (cm) | 157.97 ± 13.39 | 148.83 ± 8.27 | 149.79 ± 10.61 | 156.53 ± 10.45 | 167.46 ± 9.10 | 177.56 ± 6.35 |
| Height-for-age | 0.12 ± 1.20 | 0.50 ± 0.93 | –0.01 ± 1.29 | –0.03 ± 0.91 | –0.04 ± 1.41 | 0.83 ± 0.82 |
| Weight (kg) | 62.59 ± 19.04 | 61.56 ± 20.95 | 53.37 ± 18.75 | 62.22 ± 14.54 | 68.16 ± 16.68 | 82.39 ± 13.51 |
| Weight-for-age | 1.48 ± 1.63 | 2.73 ± 2.17 | 1.26 ± 1.71 | 1.37 ± 1.13 | 1.13 ± 1.41 | 1.59 ± 1.08 |
| Triglycerides (mg/dL) | 84.65 ± 45.82 | 103.29 ± 56.19 | 100.71 ± 51.79 | 74.17 ± 42.23 | 68.38 ± 27.56 | 68.10 ± 29.49 |
| Cholesterol (mg/dL) | 158.68 ± 32.80 | 163.12 ± 35.69 | 171.18 ± 34.88 | 161.30 ± 32.75 | 146.66 ± 25.61 | 136.00 ± 16.63 |
| Σ16PCBs | 0.77 ± 0.41 | 0.77 ± 0.37 | 0.88 ± 0.56 | 0.60 ± 0.21 | 0.75 ± 0.35 | 0.74 ± 0.17 |
| Σ8PerPCBs | 0.47 ± 0.30 | 0.41 ± 0.15 | 0.55 ± 0.43 | 0.38 ± 0.15 | 0.46 ± 0.25 | 0.46 ± 0.16 |
| Σ6NonPerPCBs | 0.24 ± 0.16 | 0.29 ± 0.19 | 0.26 ± 0.21 | 0.17 ± 0.07 | 0.23 ± 0.12 | 0.22 ± 0.06 |
| Σ7EstrogenicPCBs | 0.38 ± 0.22 | 0.40 ± 0.23 | 0.44 ± 0.29 | 0.29 ± 0.11 | 0.37 ± 0.17 | 0.35 ± 0.08 |
| Antiestrogenic PCB | 0.02 ± 0.02 | 0.02 ± 0.01 | 0.03 ± 0.02 | 0.02 ± 0.02 | 0.03 ± 0.01 | 0.02 ± 0.01 |
| Σ4MOPCBs | 0.15 ± 0.09 | 0.16 ± 0.07 | 0.17 ± 0.13 | 0.13 ± 0.06 | 0.15 ± 0.07 | 0.14 ± 0.04 |
| Σ8DOPCBs | 0.51 ± 0.29 | 0.51 ± 0.26 | 0.60 ± 0.39 | 0.40 ± 0.16 | 0.50 ± 0.25 | 0.51 ± 0.15 |
| Σ3TTOPCBs | 0.08 ± 0.04 | 0.08 ± 0.04 | 0.09 ± 0.05 | 0.06 ± 0.02 | 0.07 ± 0.03 | 0.08 ± 0.01 |
| 0.45 ± 0.35 | 0.31 ± 0.11 | 0.48 ± 0.50 | 0.40 ± 0.19 | 0.51 ± 0.35 | 0.52 ± 0.25 | |
| HCB | 0.04 ± 0.02 | 0.03 ± 0.02 | 0.04 ± 0.03 | 0.04 ± 0.02 | 0.05 ± 0.03 | 0.03 ± 0.01 |
| Lead (μg/dL) | 1.59 ± 0.97 | 1.48 ± 0.72 | 1.67 ± 0.94 | 1.25 ± 0.93 | 1.79 ± 1.03 | 1.70 ± 1.23 |
| Σ16PCB: congeners with ≥ 50% detection rate, sum of PCBs 52, 70, 74, 84, 87, 95, 99, 101[+90], 105, 110, 118, 138[+163+164], 149[+123], 153, 180, 187; Σ8PerPCBs: sum of PCBs 74, 99, 105, 118, 138[+163+164], 153, 180, 187; Σ6NonPerPCBs: sum of PCBs 52, 84, 95, 101[+90], 110, 149[+123]; Σ7EstrogenicPCBs: sum of PCBs 52, 70, 95, 99, 101[+90], 110, 153 (Cooke et al. 2001); antiestrogenic PCB: PCB-105 (Cooke et al. 2001); Σ4MOPCBs: sum of PCBs 70, 74, 105, 118 (Goncharov et al. 2009); Σ8DOPCBs: sum of PCBs 52, 87, 99, 110, 138[+163+164], 153, 101[+90] (Goncharov et al. 2009); Σ3TTOPCBs: sum of PCBs 84, 95, 187 (Goncharov et al. 2009). Brackets indicate “minor” coeluting congener based on Aroclor concentration (Hansen 1999). | ||||||
Predictors of testosterone levels in adolescent males: results of the multivariable regression analysis with PCB groupings (n = 120).
| Toxicant (ppb) | β (95% CI) | Percent change | |
|---|---|---|---|
| Σ16PCBs | –0.56 (–1.08, –0.05) | 0.03 | 5.6 |
| Σ8PerPCBs | –0.57 (–1.10, –0.04) | 0.03 | 5.7 |
| Σ6NonPerPCBs | –0.31 (–0.72, 0.09) | 0.13 | 3.1 |
| Σ7EstrogenicPCBs | –0.47 (–0.92, –0.01) | 0.05 | 4.7 |
| Antiestrogenic PCB | –0.15 (–0.59, 0.29) | 0.50 | 1.5 |
| Σ4MOPCBs | –0.62 (–1.12, –0.12) | 0.02 | 6.2 |
| Σ8DOPCBs | –0.46 (–0.93, 0.01) | 0.06 | 4.6 |
| Σ3TTOPCBs | –0.48 (–1.03, 0.07) | 0.09 | 4.8 |
| Each model controlled for Tanner stages (TS) I and II vs. III, TS IV and V vs. III, weight-for-age | |||